Phytic acid does not affect the formation of colonic aberrant crypt foci in Fe-overloaded male F344 rats

  • Lee, Yea Eun (College of Veterinary Medicine and Research Institute of Veterinary Medicine, Chungbuk National University) ;
  • Hue, Jin-Joo (College of Veterinary Medicine and Research Institute of Veterinary Medicine, Chungbuk National University) ;
  • Lee, Ki-Nam (College of Veterinary Medicine and Research Institute of Veterinary Medicine, Chungbuk National University) ;
  • Nam, Sang Yoon (College of Veterinary Medicine and Research Institute of Veterinary Medicine, Chungbuk National University) ;
  • Ahn, Byeongwoo (College of Veterinary Medicine and Research Institute of Veterinary Medicine, Chungbuk National University) ;
  • Yun, Young Won (College of Veterinary Medicine and Research Institute of Veterinary Medicine, Chungbuk National University) ;
  • Jeong, Jae-Hwang (Department of Biosciences and Bioinformatic, Chungbuk Provincial University of Science and Technology) ;
  • Lee, Beom Jun (College of Veterinary Medicine and Research Institute of Veterinary Medicine, Chungbuk National University)
  • Accepted : 2008.09.22
  • Published : 2008.12.01


There are accumulating evidences that high levels of dietary iron may play a role in colon carcinogenesis. Elevated iron status has been associated with oxidative stress. Phytic acid (PA) functions as an antioxidant by chelating divalent cations and prevents formation of reactive oxygen species responsible for cell injury and carcinogenesis. The protective effect of PA was investigated on formation of aberrant crypt foci (ACF) induced by azoxymethane (AOM) in iron-overloaded male F344 rats. After acclimation with AIN-93G purified diet (35 ppm Fe, normal control diet) for one week, animals were fed iron-overloaded diet (350 ppm Fe) and PA (0.5% or 2% PA in water) for 8 weeks. Animals received two (1st and 2nd week) injections of AOM (15 mg/kg b.w.) to induce colonic ACF. The colonic mucosa was examined for the total numbers of aberrant crypt (AC) and ACF after staining with methylene blue. The blood and serum were analyzed with a blood cell differential counter and an automatic serum analyzer. Iron-overloaded diet increased the concentration of iron in liver of the rats. But iron-related parameters in blood were not changed among experimental groups. The numbers of ACF per colon and AC per colon were $178.8{\pm}33.2$ and $448.4{\pm}110.2$ in the iron-overloaded F344 rats. The total AC was significantly increased, compared with normal-diet AOM control group (p < 0.05). The treatments of PA at the dose of 0.5% slightly decreased the number of ACF and AC per colon to $153.6{\pm}29.5$ and $396.3{\pm}107.5$. However, there were no significant differences in the total numbers of ACF and AC between the AOM control group and PA (0.5% or 2%)-treated groups. These results suggest that PA may not affect the formation of ACF or AC induced by AOM in ironoverloaded F344 rats.


  1. Babbs CF. Oxygen radicals in ulcerative colitis. Free Radic Biol Med 1992, 13, 169-181
  2. Davis CD, Feng Y. Dictary copper, manganese and iron affect the formation of aberrant crypts in colon of rats administered 3,2'-dimethyl-4-aminobiphenyl. J Nutr 1999, 129, 1060-1067
  3. Feig DI, Reid TM, Loeb LA. Reactive oxygen species in tumorigenesis. Cancer Res 1994, 54 (7 Suppl), 1890s-1894s
  4. Grar E, Eaton JW. Suppression of colonic cancer by dietary phytic acid. Nutr Cancer 1993, 19, 11-19
  5. Jcmal A, Siegel R, Ward E. Murrny T, Xu J, Smigal C, Thun MJ. Cancer statistics. 2006. CA Cancer J Clin 2006, 56, 106-130
  6. Nelson RL. Dielary iron and ooIorectaJ cancer risk. Free radic Biol Med 1992, 12, 161-168
  7. Soyan KE, Fischer JG. Iron supplementation does not affect cell proliferation or aberrant crypt foei development in the colon of sprague-dawley rats. J Nutr 1998, 128, 764-770
  8. Wurulmann JI, Silver A, Schreinemaehers DM, Sandler RS, Everson RB. Iron intake and the risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 1996, 5, 503-507
  9. Cheng L, Lai MD. Aberrant crypt foci as microscopic precursors of colorectal cancer. World J Gastroenterol 2003, 9, 2642-2649
  10. Knobel Y, GIei M, Osswald K, Pool-Zobel BL. Ferric iron increases ROS fomllltion. modulates cell growth and enhances genotoxic damage by 4-hydroxynonenal in human colon tumor cell. Toxicol In Vitro 2006, 20, 793-800
  11. Raboy V. Seeds for a better future: 'Iow phytate' grains help to overcome malnutrition and reduce pollution. Trends Plant Sci 2001, 6, 458-462
  12. Huang C, Ma WY, Uetht SS, Dong Z. Inositol hexaphosphate inhibits cell transformation and activator protein I activation by targeting phosphatidylinosilol- 3' kinase. Cancer Res 1997, 57, 2873-2878
  13. Liu Z, Tomotake H, Wan G, Watanabe H, Kalo N. Combined effect of dietary calciwn and iron on colonic aberrant crypt foci, cell proliferation and apoptosis. and fecal bile acids in 1,2-dimethylhydrazine-treated rats. Oncol Rep 2001, 8, 893-897
  14. Sandhu MS, White IR. MePherson K. Systematic review of the prospective cohort studies on meat consumption and colorectal cancer risk: a meta-analytical approach. Cancer Epidemiol Biomarkers Prev 2001, 10, 439-446
  15. KIaunig JE, Xu Y, Isenberg JS. Bachowski S. Koiaja KL, Jiang J, Stevenson DE, Walborg EF Jr. The role of oxidative stresS in chemical carcinogenesis. Environ Health Perspect 1998, 106 (Suppl 1), 289-295
  16. Hann HW, Stahlhul MW. Menduke H. Iron enhances tumor growth. Observation on spontaneous mammary tumors in mice. Cancer 1991, 68, 2407-2410<2407::AID-CNCR2820681113>3.0.CO;2-N
  17. Predow TP, O'Riordan MA, Somieh GA, AmiDi SB, Pretlow TG. Aberrant crypts correlate with tumor incidence in F344 rats trcated with azoxymethane and phytate. Carcinogenesis 1992, 13, 1509-1512
  18. Zhang Z, Song Y, Wang XL. Inositol hcxaphosphateinduced enhancement of natunli killer cell activity correlates with suppression of colon carcinogenesis in rats. World J Gastroenterol 2005, 11, 5044-5046
  19. Baten A. UIIah A, Tomazic VJ, Shamsuddin AM. lnositol-phosphate-induced enhancement of natural killer cell activity correlates with tumor suppression. Carcinogenesis 1989, 10, 1595-1598
  20. Shamsuddin AM. Inositol phosphates have novel anticancer function. J Nutr 1995, 125 (3 Suppl), 725S-732S
  21. Rodrigo L, Hieslra S. Diet and colon cancer. Rev Esp Enferm Dig 2007, 99, 183-189
  22. UlIah A, Shamsuddin AM. Dose-dependent inhibition of large intestinal cancer by inositol hexaphosphate in F344 rats. Carcinogenesis 1990, 11, 2219-2222
  23. Graf E, Empson KL, Eaton JW. Phytic acid. A natural antioxidant. J Biol Chem 1987, 262, 11647-11650
  24. Khatiwada J, Verghese M, Walker LT. Shackelford L, Chawan CB, Sunkara R. Combination of green tea, phytic acid, and inositol reduced the incidence of azoxymethane-induced colon tumors in Fisher 344 male rats. Lebenson Wiss Technol 2006, 39, 1080-1086
  25. Shamsuddin AM, Ullah A, Chakravarthy AK. Inositol and inositol hexaphosphate suppress cell proliferation and tumor' formation in CD-1 mice. Carcinogenesis 1989, 10, 1461-1463
  26. Saied IT, Shamsuddin AM. Up-regulation of the tumor suppressor gene p53 and WAF1 gene expression by IP6 in HT-29 hwnan colon carcinoma cell line. Anticancer Res 1998, 18, 1479-1484
  27. Dypbukt JM. Ankarcrona M, Burkitt M. Sjoholm A. Strom K, Omnius S, Nicotcra P. Different prooxidant levels stimulate growth, trigger apoplosis, or produce necrosis of insulin-secreting RINm5F cells. The role of intracellular polyamines. J Biol Chem 1994, 269, 30553-30560
  28. Korea national statistical office (KNSO). Death and cause of death statistics 2006, KNSO, Daejcon. 2007
  29. Lund EK, Wharf SG, Fairweather-Tait SJ, Johnson IT. Increases in the concentrations of available iron in response to dielary iron supplemenlalion are associated with changes in crypt cell proliferation in rat large intestine. J Nutr 1998, 128, 175-179
  30. EI-Shcrbiny YM, Cox MC, Ismail ZA, Shamsuddin AM, Vucenik I. G0/G1 arrest and S phase inhibition of human cancer cell lines by inositol hexaphosphate (IP6). Anticancer Res 2001, 21, 2393-2403
  31. McLellan EA, Bird RP. Aberrant crypts: potential preneoplaslic lesions in the murine colon. Cancer Res 1988, 48, 6187-6192
  32. Shamsuddin AM. Pbytate and coIon-cancer risk. Am J Clin Nutr 1992, 55, 478
  33. Hann HW. Stahlhut MW, Rlumberg BS. Iron nutrition and tumor growth: decreased tumor growth in iron-deficient mice. Cancer Res 1988, 48, 4168-4170
  34. Midorikawa K, Muratll M, Oikawla S, Hirakn Y, Kawanishi S. Protective effect of phytic acid on oxidative DNA damage with reference to cancer chemoprevention. Bioehcm Biophys Res Commun 2001, 288, 552-557
  35. Siegers CP, Bumann D, Trepkau HD, Schadwiokel B, Baretton G. Influence of dieuuy iron overload on cell proliferation and intestinal tumorigenesis in mice. Cancer Lett 1992, 65, 245-249
  36. Bird RP. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 1987, 37, 147-151
  37. Shamsuddin AM, Vucenik I, Cole KE. IP6: a novel anti-cancer agent. Life Sci 1997, 61, 343-354
  38. Babbs CF. Free radicals and the ctiology of colon cancer. Free Radic Biol Med 1990, 8, 191-200
  39. Oong Z, Huang C, Ma WY. PI-3 kinase in signal transduction, cell transfomlation, and as a target for chemoprevemion of cancer. Anticancer Res 1999, 19, 3743-3747
  40. IIsley JN, Belinsky GS. Guda K, Zhang Q, Huang X, Blumberg JB, Milbury PE, Roberts LJ 2nd. Stevens RG, Rosenberg DW. Dictary iron promotes azoxymethane-induced colon tumors in mice. Nutr Cancer 2004, 49, 162-169
  41. Guylon KZ, Kensler TW. Oxidative mechanisms in carcinogenesis. Br Med Bull 1993, 49, 523-544
  42. Hata Y, Kawabe T, Hiraishi H, Ota S, Terano A, Ivcy KJ. Hydrogen peroxide-mediated cytotoxicity tp cultured colonic epithelial cells. Life Sci 1997, 60, 2221-2230